$POAI
Predictive Oncology Inc.

2021 Q4 Form 10-Q Financial Statement

#000117184321007808 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $476.5K $313.7K $480.8K
YoY Change 64.31% -34.76% -8.02%
Cost Of Revenue $136.2K $110.2K $175.2K
YoY Change 51.36% -37.12% -15.81%
Gross Profit $340.3K $203.5K $305.6K
YoY Change 70.14% -33.4% -2.88%
Gross Profit Margin 71.41% 64.88% 63.56%
Selling, General & Admin $3.849M $2.234M $2.348M
YoY Change 79.03% -4.85% -23.06%
% of Gross Profit 1131.2% 1097.96% 768.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $369.8K $237.7K $236.6K
YoY Change 23.27% 0.48% 80.82%
% of Gross Profit 108.68% 116.83% 77.43%
Operating Expenses $4.756M $2.234M $2.348M
YoY Change 66.3% -4.85% -23.06%
Operating Profit -$4.416M -$5.494M -$5.608M
YoY Change 66.01% -2.05% 62.81%
Interest Expense $96.02K $4.120K $1.400M
YoY Change -79.13% -99.71%
% of Operating Profit
Other Income/Expense, Net $44.99K $51.42K -$2.100M
YoY Change -98.05% -102.45% 275.0%
Pretax Income -$8.418M -$5.438M -$6.310M
YoY Change -26.61% -13.82% 57.36%
Income Tax -$661.7K
% Of Pretax Income
Net Earnings -$7.757M -$5.438M -$6.308M
YoY Change -32.38% -13.79% 57.36%
Net Earnings / Revenue -1627.84% -1733.71% -1312.04%
Basic Earnings Per Share -$0.08 -$0.46
Diluted Earnings Per Share -$118.1K -$0.08 -$0.46
COMMON SHARES
Basic Shares Outstanding 65.58M 65.41M 15.03M
Diluted Shares Outstanding 65.41M 15.03M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.20M $41.77M $2.470M
YoY Change 4047.44% 1591.15% 2370.0%
Cash & Equivalents $28.20M $41.77M $2.474M
Short-Term Investments
Other Short-Term Assets $513.8K $595.2K $270.0K
YoY Change 77.17% 120.45% 107.69%
Inventory $387.7K $398.0K $205.9K
Prepaid Expenses
Receivables $354.2K $275.2K $508.3K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $29.46M $43.04M $3.458M
YoY Change 1845.42% 1144.73% 225.4%
LONG-TERM ASSETS
Property, Plant & Equipment $2.512M $3.811M $3.755M
YoY Change -34.3% 1.47% 129.87%
Goodwill $6.858M $0.00 $12.69M
YoY Change 143.72% -100.0% -46.65%
Intangibles $3.962M $3.199M $3.464M
YoY Change 16.6% -7.66% -23.16%
Long-Term Investments
YoY Change
Other Assets $167.1K $179.1K
YoY Change 43.7%
Total Long-Term Assets $14.31M $8.150M $21.70M
YoY Change 23.96% -62.45% -29.58%
TOTAL ASSETS
Total Short-Term Assets $29.46M $43.04M $3.458M
Total Long-Term Assets $14.31M $8.150M $21.70M
Total Assets $43.77M $51.19M $25.16M
YoY Change 235.14% 103.45% -21.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.022M $1.030M $1.629M
YoY Change -25.53% -36.8% -56.71%
Accrued Expenses $1.263M $940.9K $2.530M
YoY Change -51.21% -62.82% 40.02%
Deferred Revenue $187.0K $152.5K $66.12K
YoY Change 252.55% 130.7% 115.82%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00 $7.873M
YoY Change -100.0%
Total Short-Term Liabilities $3.241M $2.986M $11.61M
YoY Change -65.29% -74.28% 7.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $25.42K $30.90K $95.08K
YoY Change -89.22% -67.5% -75.62%
Total Long-Term Liabilities $25.42K $30.90K $95.08K
YoY Change -89.22% -67.5% -75.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.241M $2.986M $11.61M
Total Long-Term Liabilities $25.42K $30.90K $95.08K
Total Liabilities $3.506M $3.405M $12.92M
YoY Change -66.35% -73.65% 15.72%
SHAREHOLDERS EQUITY
Retained Earnings -$128.0M -$120.3M -$96.91M
YoY Change 18.14% 24.12% 40.57%
Common Stock $656.1K $654.6K $165.9K
YoY Change 231.31% 294.48% 426.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.27M $47.78M $12.24M
YoY Change
Total Liabilities & Shareholders Equity $43.77M $51.19M $25.16M
YoY Change 235.14% 103.45% -21.08%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$7.757M -$5.438M -$6.308M
YoY Change -32.38% -13.79% 57.36%
Depreciation, Depletion And Amortization $369.8K $237.7K $236.6K
YoY Change 23.27% 0.48% 80.82%
Cash From Operating Activities -$3.744M -$2.938M -$3.230M
YoY Change 62.08% -9.05% 70.9%
INVESTING ACTIVITIES
Capital Expenditures -$197.1K -$131.4K -$120.0K
YoY Change -1.45% 9.54% 1100.0%
Acquisitions
YoY Change
Other Investing Activities -$9.590M -$55.00K $0.00
YoY Change -16083.68%
Cash From Investing Activities -$9.787M -$186.5K -$120.0K
YoY Change 6890.94% 55.38% 1100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -37.49K 14.78K 2.430M
YoY Change -105.77% -99.39% 25.26%
NET CHANGE
Cash From Operating Activities -3.744M -2.938M -3.230M
Cash From Investing Activities -9.787M -186.5K -120.0K
Cash From Financing Activities -37.49K 14.78K 2.430M
Net Change In Cash -13.57M -3.110M -920.0K
YoY Change 653.83% 237.99% -2400.0%
FREE CASH FLOW
Cash From Operating Activities -$3.744M -$2.938M -$3.230M
Capital Expenditures -$197.1K -$131.4K -$120.0K
Free Cash Flow -$3.547M -$2.806M -$3.110M
YoY Change 68.11% -9.76% 65.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65576334
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
244830 USD
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65457484
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19804787
us-gaap Interest Paid Net
InterestPaidNet
144791 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
313663 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
480757 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
944187 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
958484 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5438017 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6307726 USD
us-gaap Net Income Loss
NetIncomeLoss
-11900662 USD
us-gaap Net Income Loss
NetIncomeLoss
-14414421 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41771515 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
289535 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
275193 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
256878 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
397976 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
678332 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
595224 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
289490 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
43039908 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1514235 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3810640 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3822700 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3199047 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3398101 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
961419 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1395351 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
179096 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
116257 USD
CY2021Q3 us-gaap Goodwill
Goodwill
0 USD
CY2020Q4 us-gaap Goodwill
Goodwill
2813792 USD
CY2021Q3 us-gaap Assets
Assets
51190110 USD
CY2020Q4 us-gaap Assets
Assets
13060436 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1029545 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1372070 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4431925 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
940892 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2588047 USD
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
225498 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
294382 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
152546 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
53028 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
637352 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
597469 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2985833 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9336921 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
388473 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
845129 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
30898 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
235705 USD
CY2021Q3 us-gaap Liabilities
Liabilities
3405204 USD
CY2020Q4 us-gaap Liabilities
Liabilities
10417755 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
654575 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
198048 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
167413309 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110826949 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120283770 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108383108 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
47784906 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2642681 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51190110 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13060436 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
313663 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
480757 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
944187 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
244214 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3993969 USD
CY2021Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
4122 USD
CY2020Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1402768 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
68884 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1007794 USD
CY2021Q3 poai Gain Loss On Receivable Previously Considered Uncollectable
GainLossOnReceivablePreviouslyConsideredUncollectable
0 USD
CY2020Q3 poai Gain Loss On Receivable Previously Considered Uncollectable
GainLossOnReceivablePreviouslyConsideredUncollectable
0 USD
poai Gain Loss On Receivable Previously Considered Uncollectable
GainLossOnReceivablePreviouslyConsideredUncollectable
0 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
958484 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
110165 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
175206 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
350800 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
353124 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
203498 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
305551 USD
us-gaap Gross Profit
GrossProfit
593387 USD
us-gaap Gross Profit
GrossProfit
605360 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2061458 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2226634 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7410208 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8266927 USD
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
648935 USD
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
568766 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1791543 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1638635 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
172869 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
121514 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
447298 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
518938 USD
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2813792 USD
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2997000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2813792 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2997000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5493556 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5608363 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11869454 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-12816140 USD
CY2021Q3 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
58830 USD
CY2020Q3 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
44926 USD
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
144122 USD
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
97894 USD
CY2021Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7413 USD
CY2020Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2147057 USD
poai Gain Loss On Receivable Previously Considered Uncollectable
GainLossOnReceivablePreviouslyConsideredUncollectable
1290000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5438017 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6307726 USD
us-gaap Net Income Loss
NetIncomeLoss
-11900662 USD
us-gaap Net Income Loss
NetIncomeLoss
-14414421 USD
CY2021Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0 USD
CY2020Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
554287 USD
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0 USD
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
554287 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5438017 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6862013 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11900662 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
10355390 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
62373 USD
CY2020Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2192878 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
12236766 USD
us-gaap Net Income Loss
NetIncomeLoss
-11900662 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14968708 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.08
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.46
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.51
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65406312
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15026789
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51272960
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9935738
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2642681 USD
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
143573 USD
CY2021Q1 poai Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
4495270 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
514011 USD
CY2021Q1 poai Stock Issued During Period Value Issued For Services And Other Adjustments
StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments
-4048 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
565082 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3888713 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
35545087 USD
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2021Q2 poai Stock Issued During Period Value Inducement To Equity Line
StockIssuedDuringPeriodValueInducementToEquityLine
588590 USD
CY2021Q2 poai Stock Issued During Period Value Issued For Services And Other Adjustments
StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments
48802 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
33243 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2573932 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
53088086 USD
CY2021Q3 poai Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
18590 USD
CY2021Q3 poai Stock Issued During Period Value Issued For Services And Other Adjustments
StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments
98769 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17478 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5438017 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
47784906 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11231318 USD
CY2020Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
130000 USD
CY2020Q1 poai Stock Issued During Period Value Inducement To Promissory Note Extension
StockIssuedDuringPeriodValueInducementToPromissoryNoteExtension
41250 USD
CY2020Q1 poai Issuance Of Shares And Prefunded Warrants Pursuant To Private Placement Value
IssuanceOfSharesAndPrefundedWarrantsPursuantToPrivatePlacementValue
457823 USD
CY2020Q1 poai Stock Issued During Period Value Inducement To Convertible Debt
StockIssuedDuringPeriodValueInducementToConvertibleDebt
120000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
116951 USD
CY2020Q1 poai Stock Issued During Period Value Inducement To Equity Line
StockIssuedDuringPeriodValueInducementToEquityLine
1869899 USD
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
362300 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
287838 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4529317 USD
CY2020Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
186300 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
35000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
134939 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3577378 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
11691158 USD
CY2020Q3 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
1470267 USD
CY2020Q3 poai Adjustments To Additional Paid In Capital Repricing And Reclassification Of Warrants
AdjustmentsToAdditionalPaidInCapitalRepricingAndReclassificationOfWarrants
1865953 USD
CY2020Q3 poai Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
192150 USD
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3031 USD
CY2020Q3 poai Stock Issued During Period Value Inducement To Equity Line
StockIssuedDuringPeriodValueInducementToEquityLine
2359803 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
24000 USD
CY2020Q3 poai Adjustments To Additional Paid In Capital Vesting Expense And Option Repricing
AdjustmentsToAdditionalPaidInCapitalVestingExpenseAndOptionRepricing
134675 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6307726 USD
us-gaap Net Income Loss
NetIncomeLoss
-14414421 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
25739 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-204807 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8464821 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9953785 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
714534 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114180 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
133850 USD
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
55000 USD
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
-0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
50699 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
45862 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-820233 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
970488 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
716595 USD
us-gaap Share Based Compensation
ShareBasedCompensation
627329 USD
us-gaap Share Based Compensation
ShareBasedCompensation
557452 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
244830 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
996271 USD
poai Gain Losses On Debt Revaluation
GainLossesOnDebtRevaluation
68884 USD
poai Gain Losses On Debt Revaluation
GainLossesOnDebtRevaluation
1007794 USD
poai Debt Extinguishment Costs
DebtExtinguishmentCosts
0 USD
poai Debt Extinguishment Costs
DebtExtinguishmentCosts
1996681 USD
poai Equity Instruments Issued Conversion Of Convertible Debt
EquityInstrumentsIssuedConversionOfConvertibleDebt
-0 USD
poai Equity Instruments Issued Conversion Of Convertible Debt
EquityInstrumentsIssuedConversionOfConvertibleDebt
-20695 USD
poai Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
143523 USD
poai Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
424331 USD
poai Gain Loss On Receivable Previously Considered Uncollectable
GainLossOnReceivablePreviouslyConsideredUncollectable
-0 USD
poai Gain Loss On Receivable Previously Considered Uncollectable
GainLossOnReceivablePreviouslyConsideredUncollectable
1290000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5858 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-120577 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2813792 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2997000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18315 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
122003 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
108441 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15752 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
313573 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
109060 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-342525 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1438033 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-412952 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
587937 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
99518 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26192 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50523527 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
2761867 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4513860 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1935854 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
4162744 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1459973 USD
poai Proceeds From Issuance Of Stock Pursuant To Equity Line
ProceedsFromIssuanceOfStockPursuantToEquityLine
588590 USD
poai Proceeds From Issuance Of Stock Pursuant To Equity Line
ProceedsFromIssuanceOfStockPursuantToEquityLine
4229702 USD
poai Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts
5057919 USD
poai Payments For Penalties
PaymentsForPenalties
1073470 USD
poai Payments For Penalties
PaymentsForPenalties
247327 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11526 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
25416 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50378237 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12303458 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
41093183 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2323481 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
678332 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
150831 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41771515 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2474312 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
267328 USD
poai Stock Issued During Period Shares Exchange Agreement
StockIssuedDuringPeriodSharesExchangeAgreement
0
poai Stock Issued During Period Shares Exchange Agreement
StockIssuedDuringPeriodSharesExchangeAgreement
2322878
poai Stock Issued During Period Value Exchange Agreement Accrued Interest
StockIssuedDuringPeriodValueExchangeAgreementAccruedInterest
143573 USD
poai Stock Issued During Period Value Exchange Agreement Accrued Interest
StockIssuedDuringPeriodValueExchangeAgreementAccruedInterest
0 USD
poai Fixed Assets Sold For Accounts Receivable
FixedAssetsSoldForAccountsReceivable
0 USD
poai Fixed Assets Sold For Accounts Receivable
FixedAssetsSoldForAccountsReceivable
89207 USD
poai Derivatives Debt Issued
DerivativesDebtIssued
0 USD
poai Derivatives Debt Issued
DerivativesDebtIssued
636563 USD
poai Inducement Shares Issued For Debt Extension
InducementSharesIssuedForDebtExtension
514011 USD
poai Inducement Shares Issued For Debt Extension
InducementSharesIssuedForDebtExtension
140555 USD
poai Stock And Notes Issued
StockAndNotesIssued
0 USD
poai Stock And Notes Issued
StockAndNotesIssued
1470267 USD
poai Increase In Operating Lease Right Of Asset And Lease Liability Due To Lease Modification
IncreaseInOperatingLeaseRightOfAssetAndLeaseLiabilityDueToLeaseModification
0 USD
poai Increase In Operating Lease Right Of Asset And Lease Liability Due To Lease Modification
IncreaseInOperatingLeaseRightOfAssetAndLeaseLiabilityDueToLeaseModification
1417076 USD
poai Warrants Issued Debt Issuance
WarrantsIssuedDebtIssuance
0 USD
poai Warrants Issued Debt Issuance
WarrantsIssuedDebtIssuance
179324 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Stock Issued1
StockIssued1
1492500 USD
us-gaap Interest Paid Net
InterestPaidNet
695989 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41771515 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
0 USD
CY2021Q1 poai Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts
31077231 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Reclassifications</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain reclassifications have been made to the prior years’ condensed consolidated financial statements to conform to the current year presentation. The reclassifications had <em style="font: inherit;">no</em> effect on previously reported results of operations, cash flows or stockholders’ equity.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
222898 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
95898 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
161910 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
151366 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13168 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
42271 USD
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
275193 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
256878 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
152546 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
53028 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
234357 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
227805 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Credit Risk</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high credit quality financial institutions and, by policy, generally limits the amount of credit exposure to any <em style="font: inherit;">one</em> financial institution. The Company has <em style="font: inherit;">zero</em> credit risk for cash amounts held in a single institution that are in excess of amounts issued by the Federal Deposit Insurance Corporation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q3 us-gaap Inventory Net
InventoryNet
397976 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
289535 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5854280 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5154547 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2043640 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1331847 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3810640 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3822700 USD
us-gaap Depreciation
Depreciation
720736 USD
us-gaap Depreciation
Depreciation
485648 USD
CY2021Q3 us-gaap Depreciation
Depreciation
237742 USD
CY2020Q3 us-gaap Depreciation
Depreciation
236599 USD
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4177119 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
978072 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3199047 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4126421 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
728320 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3398101 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
249752 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
230947 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
83619 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77258 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
83940 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
224511 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
187428 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
187428 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
187428 USD
CY2021Q3 poai Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
2328312 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3199047 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
8100000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2997000 USD
CY2020Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
9879458 USD
CY2018Q4 us-gaap Goodwill
Goodwill
0 USD
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
23790290 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
8100000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
15690290 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
12876498 USD
CY2020Q4 us-gaap Goodwill
Goodwill
2813792 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2813792 USD
CY2021Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
23790290 USD
CY2020Q4 us-gaap Goodwill
Goodwill
2813792 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2813792 USD
CY2021Q3 us-gaap Goodwill
Goodwill
0 USD
CY2021Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
0 USD
CY2020Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4676755 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
-0 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
244830 USD
CY2021Q3 us-gaap Notes Payable
NotesPayable
0 USD
CY2020Q4 us-gaap Notes Payable
NotesPayable
4431925 USD
CY2021Q1 poai Sale Of Stock Agent Placement Fee Percent Of Gross Proceeds
SaleOfStockAgentPlacementFeePercentOfGrossProceeds
0.075 pure
CY2021Q1 poai Sale Of Stock Management Fee Percent Of Gross Proceeds
SaleOfStockManagementFeePercentOfGrossProceeds
0.01 pure
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
22531864
CY2021Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
34396319 USD
CY2021Q1 poai Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts
31077231 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1402768 USD
CY2020Q3 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
2669408 USD
CY2020Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
1052494 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29004 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
134675 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
627329 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
557452 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
50989 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
27107 USD
CY2020Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
2814798 USD
CY2020Q2 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
1701756 USD
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-422081 USD
CY2020Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
4629570 USD
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
758112 USD
CY2020Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
294382 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
95671 USD
CY2021Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
198711 USD
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-30909 USD
CY2021Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
229620 USD
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
4122 USD
CY2021Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
225498 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5438017 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6862013 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11900662 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14968708 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65406312
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15026789
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51272960
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9935738
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65406312
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15026789
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51272960
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9935738
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
CY2021Q3 us-gaap Assets
Assets
51190110 USD
CY2020Q4 us-gaap Assets
Assets
13060436 USD

Files In Submission

Name View Source Status
0001171843-21-007808-index-headers.html Edgar Link pending
0001171843-21-007808-index.html Edgar Link pending
0001171843-21-007808.txt Edgar Link pending
0001171843-21-007808-xbrl.zip Edgar Link pending
ex_302338.htm Edgar Link pending
ex_302339.htm Edgar Link pending
ex_302340.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
poai-20210930.xsd Edgar Link pending
poai-20210930_cal.xml Edgar Link unprocessable
poai-20210930_def.xml Edgar Link unprocessable
poai-20210930_lab.xml Edgar Link unprocessable
poai-20210930_pre.xml Edgar Link unprocessable
poai20210930_10q.htm Edgar Link pending
poai20210930_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending